Scott Henry
Stock Analyst at Alliance Global Partners
(1.25)
# 3,720
Out of 5,127 analysts
60
Total ratings
37.74%
Success rate
-5.64%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.01 | +197.03% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.27 | +195.51% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.24 | +167.86% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $7.66 | +30.55% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $9.42 | +337.90% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.32 | +16.12% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.13 | +253.98% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $4.36 | +244.43% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.34 | +3,407.75% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.75 | +11.19% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.36 | +25.48% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $32.01 | -25.02% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $198.56 | -54.67% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $22.58 | -31.36% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $84.03 | -30.98% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $99.06 | -63.66% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.21 | +812.86% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.50 | +33.33% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $1.22 | +473,151.03% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.60 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $1.02 | +586.27% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $15.31 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.09 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.01
Upside: +197.03%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.27
Upside: +195.51%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.24
Upside: +167.86%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $7.66
Upside: +30.55%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $9.42
Upside: +337.90%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.32
Upside: +16.12%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.13
Upside: +253.98%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $4.36
Upside: +244.43%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.34
Upside: +3,407.75%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.75
Upside: +11.19%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $10.36
Upside: +25.48%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $32.01
Upside: -25.02%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $198.56
Upside: -54.67%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $22.58
Upside: -31.36%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $84.03
Upside: -30.98%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $99.06
Upside: -63.66%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.21
Upside: +812.86%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.50
Upside: +33.33%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $1.22
Upside: +473,151.03%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.60
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $1.02
Upside: +586.27%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $15.31
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $9.09
Upside: -